Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Results & Closure of Trading Window

 Zydus Wellness Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 25, 2016, to consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2016.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will...
07-10-2016
Bigul

Zydus to market immunosuppressant drug of Switzerland's Neovii in India

 The company has inked in-licensing pact with Swiss firm for the launches Grafalon, an immunosuppressant extensively used in solid organ transplants and stem cell transplant
06-10-2016

Zydus partners Takeda to develop, market vaccine for chikungunya

 The broad-based agreement between Zydus and Takeda includes early-stage development to the final commercialisation of the vaccine for chikungunya
20-09-2016
Bigul

Zydus acquires derma brand Melgain from Issar Pharma

 The brand will be marketed by Liva Healthcare, the group's division catering to dermatological segment
08-08-2016
Bigul

Outcome of AGM

 Zydus Wellness Ltd has submitted to BSE a copy of the proceedings of the 22nd Annual General Meeting (AGM) of the Company held on August 03, 2016.
03-08-2016
Bigul

Results of E-Voting and Poll of AGM

 Zydus Wellness Ltd has informed BSE regarding announcement of the consolidated Results of E-Voting and Poll conducted at the Twenty Second Annual General Meeting of the Company held on August 03, 2016.
03-08-2016

Zydus Wellness Q1 profit up 20.12% at Rs23.46 crore

 Consolidated total income of Zydus Wellness rises to `108.78 crore in June quarter as against `96.82 crore in the year ago period
02-08-2016
Bigul

Standalone & Consolidated Financial Results, Limited Review Report, Results Press Release for June 30, 2016

 Zydus Wellness Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Consolidated Financial Results for the period ended June 30, 20163. Standalone Limited Review for the period ended June 30, 20164. Consolidated Limited Review for the period ended June 30, 20165. Result Press Release for the period ended June 30, 2016
02-08-2016
Bigul

Schedule of Analyst/Institutional Investors' meet

 Zydus Wellness Ltd has informed BSE that the Company has planned investor interaction through a conference call on August 02, 2016 at 4:00 p.m. post announcement of unaudited financial results for the quarter ended on June 30, 2016.The details of the conference call is uploaded on the website of the Company.
22-07-2016
Bigul

AGM on August 03, 2016

 Zydus Wellness Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company will be held on August 03, 2016.
11-07-2016
Next Page
Close

Let's Open Free Demat Account